Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16889-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- C1qC antibody
- Antibody type
- Polyclonal
- Description
- C1qC antibody (Cat. #16889-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Early Transcriptomic and Pathologic Changes of Col8a2 Mutant Fuchs Endothelial Corneal Dystrophy.
C/EBP-β-regulated complement hyperactivation in spleen of SFTSV-infected mice: A clue to targeted complement therapy.
Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies.
Upregulation of C1QC as a Mediator of Blood-Brain Barrier Damage in Type 2 Diabetes Mellitus.
Identification of crucial genes through WGCNA in the progression of gastric cancer.
C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Proteomic analysis of small extracellular vesicles from the plasma of patients with hepatocellular carcinoma.
Zhao X, Duan H, Dou S, Li X, Lin Y, Zhao C, Li D, Zhou L, Li Z, Zhou Q
Investigative ophthalmology & visual science 2026 Jan 5;67(1):53
Investigative ophthalmology & visual science 2026 Jan 5;67(1):53
C/EBP-β-regulated complement hyperactivation in spleen of SFTSV-infected mice: A clue to targeted complement therapy.
Liu Y, Xu M, Huang X, Liu X, Fan K, Zhang Y, Xing C, Tang H, Jiang J, Xu K, He M, Xu G, Zhang C
PLoS pathogens 2026 Apr;22(4):e1014144
PLoS pathogens 2026 Apr;22(4):e1014144
Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies.
Yang Y, Zhang Y, Li Y, Zhou X, Honda K, Kang D, Wang M, Yang JH, Xia Z, Wei Y, Liu L, Hu R, Takaki T, Xing G
Scientific reports 2025 Jan 2;15(1):495
Scientific reports 2025 Jan 2;15(1):495
Upregulation of C1QC as a Mediator of Blood-Brain Barrier Damage in Type 2 Diabetes Mellitus.
Huang C, Lin J, Chen L, Sun W, Xia J, Wu M
Molecular neurobiology 2025 Apr;62(4):5234-5251
Molecular neurobiology 2025 Apr;62(4):5234-5251
Identification of crucial genes through WGCNA in the progression of gastric cancer.
Liu R, Liu J, Cao Q, Chu Y, Chi H, Zhang J, Fu J, Zhang T, Fan L, Liang C, Luo X, Yang X, Li B
Journal of Cancer 2024;15(11):3284-3296
Journal of Cancer 2024;15(11):3284-3296
C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W, Liu H, Xu F, Cai Z, Hang L, Lu M, Zhao Y, Yang C, Zong Y
Frontiers in genetics 2023;14:1109991
Frontiers in genetics 2023;14:1109991
Proteomic analysis of small extracellular vesicles from the plasma of patients with hepatocellular carcinoma.
Dong W, Xia Z, Chai Z, Qiu Z, Wang X, Yang Z, Wang J, Zhang T, Zhang Q, Jin J
World journal of surgical oncology 2022 Dec 6;20(1):387
World journal of surgical oncology 2022 Dec 6;20(1):387
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The C1QC antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human C1QC. This antibody recognizes human antigen. The C1QC antibody has been validated for the following applications: ELISA, WB analysis.
